To investigate potential clinical importance of prohibitin in breast cancer development, tumors from twenty-three patients with sporadic breast cancer were surveyed and four somatic mutations of the prohibitin gene were identified (Sato et al. 1992; Sato et al. 1993). Here, PHB1 is linked to breast carcinoma.